ausbiz interview with ceo marc voigt, march 17, 2021, immutep limited (asx: imm; nasdaq: immp)
Published 3 years ago • 380 plays • Length 5:58
Download video MP4
Download video MP3
Similar videos
-
12:28
immutep (asx:imm, nasdaq:immp) ceo marc voigt provides an update on clinical trials
-
4:32
immutep limited (asx:imm; nasdaq:immp) ceo and executive director marc voigt provides company update
-
7:13
from the helm: immutep's (asx:imm, nasdaq:immp) executive director & ceo marc voigt
-
27:17
immutep limited (asx:imm, nasdaq:immp) - fireside chat with immutep limited
-
7:13
from the helm: immutep's (asx:imm) executive director & ceo marc voigt
-
52:42
the interview - michael gutman obe, assembly funds management
-
30:25
workforce australia self-employment and entrepreneurship podcast episode #1 – connect for success
-
53:32
exploring science and ai investing with josh wolfe (lux capital)
-
10:01
immutep limited (asx:imm, nasdaq:immp) encouraging results for immutep's cancer therapies
-
6:03
immutep (asx:imm, nasdaq:immp) reports positive discussions with the fda and strong survival data
-
17:30
18 minutes with immutep ceo marc voigt
-
47:53
immutep (asx:imm, nasdaq:immp) tacti-003 results, june 2024
-
23:47
benzinga biotech small cap conference: immutep limited (asx:imm, nasdaq:immp) march 24, 2021
-
31:08
immutep (asx:imm) 2023 agm - ceo presentation
-
4:44
immutep (asx:imm, nasdaq:immp) - innovative cancer therapies
-
7:43
immutep (asx:imm; nasdaq: immp) company update on start of 2021
-
4:40
immutep (asx:imm, nasdaq:immp) announces encouraging trial data for lung cancer therapy
-
6:42
immutep (asx:imm, nasdaq:immp) lag-3 validated in bristol myers squibb trial
-
4:19
immutep (asx:imm) clinical trial update
-
15:49
immutep (asx:imm, nasdaq:immp) - sharecafe's "hidden gems" presentation, 17 february 2023
-
6:59
immutep (asx:imm; nasdaq: immp) global leader in development of lag 3 gene immuno-therapies
Clip.africa.com - Privacy-policy